McKesson Corporation $MCK Stock Sold by Heritage Trust Co

Heritage Trust Co lowered its stake in McKesson Corporation (NYSE:MCK – Free Report) by 21.1% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,881 shares of the company’s stock after selling 504 shares during the quarter. Heritage Trust Co’s holdings in McKesson were worth $1,606,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in the stock. BlackRock Inc. bought a new stake in shares of McKesson during the 2nd quarter valued at approximately $8,156,743,000. Bank of America Corp DE bought a new position in McKesson in the 2nd quarter valued at approximately $998,896,000. Legal & General Group Plc bought a new position in McKesson in the 2nd quarter valued at approximately $656,566,000. The Manufacturers Life Insurance Company bought a new position in McKesson in the 2nd quarter valued at approximately $651,462,000. Finally, Bank of New York Mellon Corp acquired a new stake in McKesson in the second quarter valued at approximately $599,060,000. 85.07% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at McKesson

In other news, CAO B Jr sold 111 shares of the business’s stock in a transaction that occurred on Tuesday, September 8th. The shares were sold at an average price of $891.45, for a total value of $98,950.95. Following the transaction, the chief accounting officer owned 521 shares in the company, valued at approximately $464,445.45. The trade was a 17.56% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Francisco Fraga sold 800 shares of the business’s stock in a transaction that occurred on Thursday, October 15th. The stock was sold at an average price of $995.80, for a total transaction of $796,640.00. Following the completion of the transaction, the executive vice president owned 5,423 shares in the company, valued at $5,400,223.40. This trade represents a 12.86% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 2,161 shares of company stock valued at $2,242,515. Company insiders own 0.06% of the company’s stock.

Analyst Ratings Changes

MCK has been the topic of a number of research analyst reports. UBS Group raised their target price on shares of McKesson from $1,200.00 to $1,250.00 and gave the company a “buy” rating in a research report on Thursday, November 5th. Leerink Partners upped their price target on shares of McKesson from $1,070.00 to $1,200.00 and gave the stock an “outperform” rating in a report on Thursday, November 5th. JPMorgan Chase & Co. increased their price target on McKesson from $1,042.00 to $1,255.00 and gave the company an “overweight” rating in a research note on Tuesday, November 10th. Barclays raised their price objective on McKesson from $925.00 to $1,000.00 and gave the company an “overweight” rating in a report on Wednesday, August 19th. Finally, Evercore restated an “outperform” rating and set a $950.00 price objective (down from $1,000.00) on shares of McKesson in a research report on Thursday, August 6th. Fifteen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $1,040.29.

Check Out Our Latest Stock Analysis on MCK

McKesson Price Performance

Shares of MCK opened at $1,103.31 on Monday. McKesson Corporation has a 1 year low of $723.68 and a 1 year high of $1,121.50. The company has a market capitalization of $127.39 billion, a price-to-earnings ratio of 28.37, a price-to-earnings-growth ratio of 1.86 and a beta of 0.27. The business has a 50-day moving average of $955.45 and a 200-day moving average of $874.53.

McKesson (NYSE:MCK – Get Free Report) last posted its quarterly earnings data on Wednesday, November 4th. The company reported $11.68 EPS for the quarter, topping analysts’ consensus estimates of $10.72 by $0.96. The company had revenue of $110.96 billion for the quarter, compared to analyst estimates of $109.90 billion. McKesson had a negative return on equity of 202.94% and a net margin of 1.12%. The firm’s quarterly revenue was up 7.5% on a year-over-year basis. During the same period in the previous year, the firm earned $9.86 earnings per share. As a group, sell-side analysts anticipate that McKesson Corporation will post 46.16 EPS for the current year.

McKesson Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, January 4th. Shareholders of record on Tuesday, December 1st will be issued a dividend of $0.94 per share. The ex-dividend date is Tuesday, December 1st. This represents a $3.76 annualized dividend and a yield of 0.3%. McKesson’s dividend payout ratio (DPR) is presently 9.67%.

McKesson Company Profile

(Free Report)

McKesson Corporation is a healthcare services and information technology company that distributes pharmaceuticals and other medical products. Its customers include pharmacies, hospitals, health systems, clinics and other healthcare providers. The company also provides medical-surgical supplies and technology and services that support pharmacy operations, prescription management and care delivery. Its offerings include specialized support for oncology and other areas of care. Founded in 1833, McKesson serves customers primarily in the United States and Canada.

See Also

Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corporation (NYSE:MCK – Free Report).

Institutional Ownership by Quarter for McKesson (NYSE:MCK)

Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.